Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Palivizumab> ?p ?o. }
Showing items 1 to 70 of
70
with 100 items per page.
- Palivizumab abstract "Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV. In two Phase III clinical trials in the pediatric population, palivizumab reduced the risk of hospitalization due to RSV infection by 55% and 45%. Palivizumab is dosed once a month via intramuscular (IM) injection, to be administered throughout the duration of the RSV season.Palivizumab targets the fusion protein of RSV, inhibiting its entry into the cell and thereby preventing infection.".
- Palivizumab atcPrefix "J06".
- Palivizumab atcSuffix "BB16".
- Palivizumab casNumber "188039-54-5".
- Palivizumab drugbank "DB00110".
- Palivizumab fdaUniiCode "DQ448MW7KS".
- Palivizumab wikiPageID "6609299".
- Palivizumab wikiPageRevisionID "540935580".
- Palivizumab atcPrefix "J06".
- Palivizumab atcSuffix "BB16".
- Palivizumab casNumber "188039".
- Palivizumab chembl "1201586".
- Palivizumab chemspiderid "NA".
- Palivizumab drugbank "DB00110".
- Palivizumab eliminationHalfLife "-1728000.0".
- Palivizumab hasPhotoCollection Palivizumab.
- Palivizumab mabType "mab".
- Palivizumab medlineplus "a698034".
- Palivizumab pregnancyCategory "C".
- Palivizumab routesOfAdministration Intramuscular_injection.
- Palivizumab source "zu/o".
- Palivizumab target "RSV protein F".
- Palivizumab tradename "Synagis".
- Palivizumab type "mab".
- Palivizumab unii "DQ448MW7KS".
- Palivizumab verifiedfields "changed".
- Palivizumab verifiedrevid "458269701".
- Palivizumab subject Category:AstraZeneca.
- Palivizumab subject Category:Monoclonal_antibodies.
- Palivizumab type Abstraction100002137.
- Palivizumab type Antibody115027189.
- Palivizumab type Chemical114806838.
- Palivizumab type Compound114818238.
- Palivizumab type Macromolecule114944888.
- Palivizumab type Material114580897.
- Palivizumab type Matter100020827.
- Palivizumab type Molecule114682133.
- Palivizumab type MonoclonalAntibodies.
- Palivizumab type MonoclonalAntibody115029781.
- Palivizumab type OrganicCompound114727670.
- Palivizumab type Part113809207.
- Palivizumab type PhysicalEntity100001930.
- Palivizumab type Protein114728724.
- Palivizumab type Relation100031921.
- Palivizumab type Substance100019613.
- Palivizumab type Thing100002452.
- Palivizumab type Unit109465459.
- Palivizumab type Drug.
- Palivizumab type DrugProduct.
- Palivizumab type FunctionalSubstance.
- Palivizumab comment "Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV.".
- Palivizumab label "Palivizumab".
- Palivizumab label "Palivizumab".
- Palivizumab label "Palivizumab".
- Palivizumab label "Palivizumab".
- Palivizumab label "Palivizumab".
- Palivizumab label "パリビズマブ".
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs パリビズマブ.
- Palivizumab sameAs m.0gdn5s.
- Palivizumab sameAs Q412765.
- Palivizumab sameAs Q412765.
- Palivizumab sameAs palivizumab.
- Palivizumab sameAs DB00110.
- Palivizumab sameAs Palivizumab.
- Palivizumab wasDerivedFrom Palivizumab?oldid=540935580.
- Palivizumab isPrimaryTopicOf Palivizumab.